Predictive Value of Non-fasting Blood Lipid Levels for Cardiovascular and Cerebrovascular Events in Community Population(PICC Study)
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 6,500
- 试验地点
- 1
- 主要终点
- All-cause mortality
研究概览
简要总结
Numerous studies have shown that non-fasting blood lipid levels are closely related to the occurrence of cardiovascular and cerebrovascular events, but it is still unclear in the Chinese population. The purpose of the study is to investigate the association between non-fasting blood lipid levels and adverse outcomes in Chinese community population.
详细描述
Study population includes subjects who living in community, of any race or ethnicity, 18 or older years of age, and have provided written informed consent to provide biological sample at one or more study visits. Physical examination, questionnaire survey and biological sample collection will be conducted at baseline and the incidence of a composite of major adverse cardiovascular events will be investigated during follow-up.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •≥18 years old;
- •Signed informed consent;
- •Life expectancy is greater than 1 year.
排除标准
- •mental disorder;
- •is not willing to participate in the clinical study;
- •suffered with other disease to quite the trial;
- •violated the protocol.
结局指标
主要结局
All-cause mortality
时间窗: Through study completion, an average of 1 years
All-cause mortality was confirmed through a combination of hospital medical records, telephone contacts with patients or family members, and death registration at the Center for Disease Control and Prevention.
Cardiovascular Mortality
时间窗: Through study completion, an average of 1 years
Cardiovascular mortality was defined as death attributable to an ischemic cardiovascular cause (including fatal cardiovascular events and stroke).
Cardiovascular and cerebrovascular diseases
时间窗: Through study completion, an average of 1 years
The number of and the incidence rate of cardiovascular and cerebrovascular diseases.
次要结局
未报告次要终点